Drug Profile
Ragweed allergy vaccine sublingual - Greer Laboratories
Alternative Names: SAIL™ standardized short ragweed extract; Short ragweed extract immunotherapy - Greer Laboratories; Sublingual Allergy Immunotherapy LiquidLatest Information Update: 11 Sep 2015
Price :
$50
*
At a glance
- Originator Greer Laboratories
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 14 May 2015 No recent reports on development identified - Phase-III for Seasonal allergic rhinitis in USA (Sublingual)
- 10 Mar 2014 Development of the sublingual ragweed allergy vaccine is ongoing
- 25 Feb 2013 Additional efficacy & adverse events data from a phase III trial in Seasonal allergic rhinitis presented at the Annual Meeting of the American Academy of Allergy Asthma & Immunology (AAAAI-2013)